Debra E. Rugowski

559 total citations
15 papers, 435 citations indexed

About

Debra E. Rugowski is a scholar working on Oncology, Genetics and Molecular Biology. According to data from OpenAlex, Debra E. Rugowski has authored 15 papers receiving a total of 435 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 8 papers in Genetics and 7 papers in Molecular Biology. Recurrent topics in Debra E. Rugowski's work include Estrogen and related hormone effects (7 papers), Cancer Cells and Metastasis (4 papers) and Cancer-related Molecular Pathways (4 papers). Debra E. Rugowski is often cited by papers focused on Estrogen and related hormone effects (7 papers), Cancer Cells and Metastasis (4 papers) and Cancer-related Molecular Pathways (4 papers). Debra E. Rugowski collaborates with scholars based in United States, Spain and France. Debra E. Rugowski's co-authors include Linda A. Schuler, Jennifer H. Gutzman, Kathleen A. O’Leary, Jyoti J. Watters, Lisa M. Arendt, María J. García‐Barchino, Hallgeir Rui, Jennifer L. Brockman, Menggang Yu and Patricia J. Keely and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Oncogene.

In The Last Decade

Debra E. Rugowski

15 papers receiving 432 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Debra E. Rugowski United States	11	284	171	141	86	79	15	435
Nicholas J. Kenney United States	9	292 1.0×	251 1.5×	106 0.8×	48 0.6×	36 0.5×	11	435
Erik T. McGoldrick United States	6	191 0.7×	188 1.1×	81 0.6×	81 0.9×	28 0.4×	8	371
Justina E. Wu United States	9	225 0.8×	200 1.2×	39 0.3×	85 1.0×	39 0.5×	10	514
Dao Doan United States	7	179 0.6×	250 1.5×	30 0.2×	67 0.8×	117 1.5×	11	437
Shi‐Ming Chang United States	6	219 0.8×	285 1.7×	83 0.6×	127 1.5×	63 0.8×	8	603
Zhefu Ma United States	12	251 0.9×	551 3.2×	53 0.4×	145 1.7×	88 1.1×	12	634
Julienne Gladu Canada	8	235 0.8×	268 1.6×	34 0.2×	128 1.5×	22 0.3×	10	459
David A. Delgado United States	7	193 0.7×	245 1.4×	59 0.4×	112 1.3×	66 0.8×	10	435
Maria Teresa Vento Italy	8	153 0.5×	274 1.6×	26 0.2×	105 1.2×	28 0.4×	9	406
Yuhuan Qiao China	16	173 0.6×	333 1.9×	53 0.4×	181 2.1×	14 0.2×	29	573

Countries citing papers authored by Debra E. Rugowski

Since Specialization

Citations

This map shows the geographic impact of Debra E. Rugowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Debra E. Rugowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Debra E. Rugowski more than expected).

Fields of papers citing papers by Debra E. Rugowski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Debra E. Rugowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Debra E. Rugowski. The network helps show where Debra E. Rugowski may publish in the future.

Co-authorship network of co-authors of Debra E. Rugowski

This figure shows the co-authorship network connecting the top 25 collaborators of Debra E. Rugowski. A scholar is included among the top collaborators of Debra E. Rugowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Debra E. Rugowski. Debra E. Rugowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Rugowski, Debra E., et al.. (2023). The detection of multiple cancer types with an extended set of methylation and protein markers.. Journal of Clinical Oncology. 41(16_suppl). 3040–3040. 1 indexed citations

Allawi, Hatim T., et al.. (2022). Abstract 631: Validation of a panel of methylated DNA and protein markers for multi-cancer detection in plasma. Cancer Research. 82(12_Supplement). 631–631. 5 indexed citations

O’Leary, Kathleen A., Debra E. Rugowski, Michael P. Shea, et al.. (2021). Prolactin synergizes with canonical Wnt signals to drive development of ER+ mammary tumors via activation of the Notch pathway. Cancer Letters. 503. 231–239. 8 indexed citations

O’Leary, Kathleen A., et al.. (2019). Dynamic interactions between the extracellular matrix and estrogen activity in progression of ER+ breast cancer. Oncogene. 38(43). 6913–6925. 34 indexed citations

Campbell, Katie M., Kathleen A. O’Leary, Debra E. Rugowski, et al.. (2019). A Spontaneous Aggressive ERα+ Mammary Tumor Model Is Driven by Kras Activation. Cell Reports. 28(6). 1526–1537.e4. 20 indexed citations

Brockman, Jennifer L., Kyle T. Helzer, Debra E. Rugowski, et al.. (2018). 17β-Estradiol and ICI182,780 Differentially Regulate STAT5 Isoforms in Female Mammary Epithelium, With Distinct Outcomes. Journal of the Endocrine Society. 2(3). 293–309. 10 indexed citations

Barcus, Craig E., Kathleen A. O’Leary, Jennifer L. Brockman, et al.. (2017). Elevated collagen-I augments tumor progressive signals, intravasation and metastasis of prolactin-induced estrogen receptor alpha positive mammary tumor cells. Breast Cancer Research. 19(1). 9–9. 102 indexed citations

O’Leary, Kathleen A., Debra E. Rugowski, Ruth Sullivan, & Linda A. Schuler. (2013). Prolactin cooperates with loss of p53 to promote claudin-low mammary carcinomas. Oncogene. 33(23). 3075–3082. 16 indexed citations

O’Leary, Kathleen A., Debra E. Rugowski, Ruth Sullivan, et al.. (2013). Prolactin Activates ERα in the Absence of Ligand in Female Mammary Development and Carcinogenesis in Vivo. Endocrinology. 154(12). 4483–4492. 23 indexed citations

10.

O’Leary, Kathleen A., et al.. (2012). Prolactin Promotes Mammary Pathogenesis Independently from Cyclin D1. American Journal Of Pathology. 181(1). 294–302. 8 indexed citations

11.

Arendt, Lisa M., et al.. (2011). Prolactin-induced mouse mammary carcinomas model estrogen resistant luminal breast cancer. Breast Cancer Research. 13(1). R11–R11. 47 indexed citations

12.

Arendt, Lisa M., et al.. (2009). Ovarian hormones are not required for PRL-induced mammary tumorigenesis, but estrogen enhances neoplastic processes. Journal of Endocrinology. 203(1). 99–110. 23 indexed citations

13.

Gutzman, Jennifer H., et al.. (2007). Stat5 activation inhibits prolactin-induced AP-1 activity: distinct prolactin-initiated signals in tumorigenesis dependent on cell context. Oncogene. 26(43). 6341–6348. 43 indexed citations

14.

Gutzman, Jennifer H., et al.. (2005). Prolactin and Estrogen Enhance the Activity of Activating Protein 1 in Breast Cancer Cells: Role of Extracellularly Regulated Kinase 1/2-Mediated Signals to c-fos. Molecular Endocrinology. 19(7). 1765–1778. 55 indexed citations

15.

Gutzman, Jennifer H., Debra E. Rugowski, Matthew D. Schroeder, Jyoti J. Watters, & Linda A. Schuler. (2004). Multiple Kinase Cascades Mediate Prolactin Signals to Activating Protein-1 in Breast Cancer Cells. Molecular Endocrinology. 18(12). 3064–3075. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact